Revolutionary Organ Transplant Device & The Colorado Connection

Englewood, CO August, 2003 – Wi, Inc., an Englewood-based Medical Device Development company, announced that the U. S. Food & Drug Administration (FDA) has given clearance to market the LifePort™ Kidney Transporter, developed by Organ Recovery Systems in partner with Wi. Wi was honored to be selected as a team member, and participated in critical aspects of the project.

Wi, in taking the project from concept through and into production, was responsible for developing the disposal set of the Kidney Transporter, including the kidney container and disposable perfusion set, with special emphasis on the hardware/disposal interface. Wi’s participation in the project was unique in that it offered both product and process development.

“Portable, durable and easy-to-use, the LifePort™ Kidney Transporter is the first in a new generation of devices specifically designed to establish a continuum of organ care that spans the critical time between recovery and transplantation. LifePort™ provides a high tech alternative to the conventional static method of organ storage and transportation—a cooler filled with ice. Perfusion is the gentle pumping of an organ with a physiologic solution as a pre-treatment for transplantation”, states the Organ Recovery System press release.

According to the United Network of Organ Sharing, over 55,000 Americans are currently waiting for a kidney transplant. The United States Renal Data System believes the kidney waiting list could double in the next ten years.

Lee Travis, Lead Project Engineer for Wi stated, “It is exciting to be a part of this revolutionary new product, which will increase the viability of kidneys available for transplant”.

About Organ Recovery Systems, Inc.
Organ Recovery Systems is a privately held company developing technologies and services to improve the quality and quantity of organs, tissues, and cells for transplantation. The company is organized into three operating groups: the Perfusion Services Group helps leading transplant centers and organ procurement organizations (OPOs) by employing proprietary perfusion techniques for evaluation and therapy of traditional, expanded criteria, and nonheartbeating donor kidneys prior to transplant; the Medical Devices Group develops perfusion-based devices to improve the preservation, assessment, and treatment of organs for transplantation; and the Charleston Research Center develops new technologies for cell and tissue preservation and conducts basic and applied research to support the company’s platform of organ therapy products.

For more about Organ Recovery Systems visit http://www.organ-recovery.com.

About Wi, Inc.
Wi provides medical product development services with an emphasis on invasive, tissue contact devices, design for manufacturability and manufacturing process development. Wi specializes in the commercialization of products for the medical marketplace. Wi accomplishes this challenge by employing highly experienced and skilled people who enjoy performing all levels of tasks toward the end goal. Wi is unique, efficient and provides “affordable experience”.

For more information about Wi visit www.wiinc.net.








This article courtesy of http://www.x-organ.com.

You may freely reprint this article on your website or in your newsletter provided this courtesy notice and the author name and URL remain intact.

Submit Your Article